近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.CHUNHUI LIU*, LEI ZHANG*, YEQING HUANG*,KAI LU, TAO TAO, SHUQIU CHEN,XIAOWEN ZHANG, HAN GUAN, MING CHEN and BIN XU.MicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancerproliferation and enhancing docetaxel sensitivity. MOLECULAR MEDICINE REPORTS.2015,12:7389-7395. (通讯作者) 2.Chen M, Liu N, Chen S, Liu J, Sha G, Zhu W, Xu B.Laparoscopic inferior mesenteric-gonadal vein end-to-side by pass: a newattempt for nutcracker syndrome treatment. Ann Vasc Surg. 2015 Jun 11 3.Chen S, Xu B, Liu N, Jiang H, Zhang X, Yang Y, Liu J, Sha G, Zhu W, Chen M.Improvedeffectiveness and safety of flexible ureteroscopy for renal calculi (<2 cm):A retrospective study. Can Urol Assoc J. 2015May-Jun;9(5-6):E273-7. (通讯作者) 4.Liu CH, Tao T, Jiang L, Xu B, Zhang L, Lu K, Zhang XW, Chen SQ, Liu DC, Chen M.DNMT3A -448A>G polymorphism and cancer risk: a meta-analysis. Genet Mol Res. 2015 Apr17;14(2):3640-9. (通讯作者) 5.Liu C, Lu K, Tao T, Zhang L, Zhang X, Jiang L, Huang Y, Guan H1, Chen M, Xu B.Endothelialnitric oxide synthase polymorphisms and erectile dysfunction: a meta-analysis. J Sex Med. 2015Jun;12(6):1319-28. (通讯作者) 6.Lu K, Liu C, Tao T, Zhang X, Zhang L, Sun C, Wang Y, Chen S, Xu B, Chen M.MicroRNA-19a regulates proliferation and apoptosis of castration-resistantprostate cancer cells by targeting BTG1. FEBS Lett. 2015Jun 4;589(13):1485-90. (通讯作者) 7.Jin J, Chen L, Zhu Z, Wang Y, Chen M,Wang Q, Peng X.Magnetic resonance evaluations of correlation of iron overload and osteoporosisin ovariectomized rats. Zhonghua Yi Xue ZaZhi. 2015 Feb 17;95(7):537-40. (通讯作者) 8.Chen M, Zhou ZY, Chen JG, Tong N, Chen SQ, Yang Y, Zhang XW, Jiang H, Liu N, Liu J, Sha GZ, Zhu WD, Hua LX, Wang ZJ, Xu B.Effect of miR-146a polymorphism on biochemical recurrence risk after radicalprostatectomy in southern Chinese population. Genet Mol Res. 2014 Dec 18;13(4):10615-21. 9.Tao T, Li GF, Dong QS, Liu D, Liu DC,Liu CH Han DF,Huang YQ, Chen SQ, Xu B, ChenM. Loss of SNAIL inhibits cellular growth and metabolism through themiR-128-mediated RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancercells. Tumour Biol. 2014 Sep;35(9):8543-50. 10.Wang Y, Qu H, Zhang L, Chen S, Xu B, Lu K, Liu C, Tao T, Yang Y, Chen M. Safety and PostoperativeOutcomes of Regional versus Global Ischemia for Partial Nephrectomy: ASystematic Review and Meta-Analysis. UrolInt. 2014;94(4):428-35. (通讯作者) 11.TaoT, Liu DC, Liu CH, Xu B,Chen SQ, Yin Y, Ang L, Huang YQ, Zhang XW, ChenM. Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a drivingforce for prostate cancer development. Biochimica etBiophysica Acta-Gene Regulatory Mechanisms.2014SEP;1839(9):858-865. (通讯作者) 12.TaoT, Chen SQ, Xu B, Liu CH, Wang YD, Huang YQ, Chen M. Association between hsa-miR-34b/c rs4938723 T > Cpromoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and6,204 controls. Chinese Journal of Cancer Research.2014JUN;26(3):315-322,2014. (通讯作者) 13.ChenSQ, Liu DC,Wu JP, Xu B,Lu K,Zhu WD,ChenM. Effect of inhibiting the signal of mammalian target of rapamycin onmemory T cells. Transplan Procced, 2014 JUN;46(5):1642-1648.(通讯作者) 14.Liu D, Tao T, Xu B, Chen S,Liu C, Zhang L, Lu K, Huang Y, Jiang L, Zhang X, Huang X, Zhang L, Han C, ChenM. MiR-361-5p acts as a tumour suppressor in prostate cancer bytargeting signal transducer and activator of transcription-6 (STAT6). BiochemBiophys Res Commun. 2014 Feb 28;445(1):151-6.(通讯作者) 15.LiuDC,Xu B,Chen SQ,YanG Y,Zhang XW,Liu J,Lu K,Zhang L,Liu CH,Zhao YM.Ming Chen. Longnon-coding RNAs and prostate cancer.J Nanosce Nanotechno, 2013 MAY;13(5): 3186-3194. (通讯作者)
京公网安备 11010802027423号